Hypertriglyceridemia is known to be a feature of obesity-related NIDDM, but the patho-etiological significance of this association is obscure. The effects of triglycerides (TGs) on β-cell function and morphological changes in pancreas were examined using in vivo and in vitro approaches in male OLETF rats at ages 6, 12, and 30 weeks, with their diabetes-resistant counterpart, LETO rats, as normal controls. The results showed that, in the fasting state, plasma TGs in OLETF rats were increased 2.5-fold at age 6 weeks, 3.3-fold at age 12 weeks, and 6.2-fold at age 30 weeks, compared with age-matched LETO rats. The TG content in islets from 12-week-old OLETF rats was significantly increased when compared with those from their age-matched counterparts, but this was not the case with the 6-week-old OLETF rats. Therefore, the islets from 6-week-old rats were cultured with either free fatty acids (FFAs; 1.0 mmol/1 sodium oleate) or TG (5.0 mmoM Intralipide) for 72 h. Several abnormalities in OLETF rats were evident, in contrast to the results from control LETO rats: 1) glucose-induced insulin secretion was more inhibited by either FFAs or TGs in the presence of 27.7 mmol/l glucose, a result associated, at least in part, with reduced glucokinase activity in the islets; 2) a marked elevation in TG content was found in the islets; and 3) the deposition of fat droplets in the enlarged islets, even in the β-cells, was found by Oil Red O-insulin double staining at age 30 weeks. In conclusion, hypertriglyceridemia resulted in significant TG stores in the islets, which subsequently inhibited glucose-induced insulin secretion, at least in part, via reduced glucokinase activity in the islets. Fat droplets in islets, therefore, may play an important role in hastening the development of NIDDM in this rat model.
Skip Nav Destination
Article navigation
Original Articles|
November 01 1997
Impaired β-Cell Function and Deposition of Fat Droplets in the Pancreas as a Consequence of Hypertriglyceridemia in OLETF Rat, a Model of Spontaneous NIDDM Free
Zhi-Wei Man;
Zhi-Wei Man
Tokushima Research Institute, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Min Zhu;
Min Zhu
Otsuka Pharmaceutical Co., and the Departments of Laboratory Medicine, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Yoshihiko Noma;
Yoshihiko Noma
Otsuka Pharmaceutical Co., and the Departments of Laboratory Medicine, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Kiyotaka Toide;
Kiyotaka Toide
Tokushima Research Institute, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Takashi Sato;
Takashi Sato
Tokushima Research Institute, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Yoshihiko Asahi;
Yoshihiko Asahi
Tokushima Research Institute, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Tsukasa Hirashima;
Tsukasa Hirashima
Tokushima Research Institute, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Shigehito Mori;
Shigehito Mori
Tokushima Research Institute, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Kazuya Kawano;
Kazuya Kawano
Tokushima Research Institute, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Akira Mizuno;
Akira Mizuno
Otsuka Pharmaceutical Co., and the Departments of Laboratory Medicine, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Toshiaki Sano;
Toshiaki Sano
Pathology, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Kenji Shima
Kenji Shima
Otsuka Pharmaceutical Co., and the Departments of Laboratory Medicine, School of Medicine, the University of Tokushima
Tokushima-City, Japan
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Zhi-Wei Man, Tokushima Research Institute, Otsuka Pharmaceutical Co., 463-10, Kaga-suno, Kawauchi-Cho, Tokushima 771-01, Japan. E-mail: [email protected].
Diabetes 1997;46(11):1718–1724
Article history
Received:
January 06 1997
Revision Received:
June 23 1997
Accepted:
June 23 1997
PubMed:
9356017
Citation
Zhi-Wei Man, Min Zhu, Yoshihiko Noma, Kiyotaka Toide, Takashi Sato, Yoshihiko Asahi, Tsukasa Hirashima, Shigehito Mori, Kazuya Kawano, Akira Mizuno, Toshiaki Sano, Kenji Shima; Impaired β-Cell Function and Deposition of Fat Droplets in the Pancreas as a Consequence of Hypertriglyceridemia in OLETF Rat, a Model of Spontaneous NIDDM. Diabetes 1 November 1997; 46 (11): 1718–1724. https://doi.org/10.2337/diab.46.11.1718
Download citation file:
87
Views